Form 4 for SGMT Sagimet Biosciences Inc.
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001104659-26-014266 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | 2026-02-10 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | S - Sale | $5.36 | -2,622 | 191.0K | -1% | -$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2026-02-10 | S | D | 2,622 | $5.36 | 190,959 | D | — | — |